Nanospectra Biosciences snags funding
Nanospectra Biosciences, Inc., a medical device company, has closed on an initial $3 million in Series B-1 financing.
Nanospectra Biosciences, Inc., a medical device company, has closed on an initial $3 million in Series B-1 financing.
Copyright PEI Media
Not for publication, email or dissemination